CorporateWelcure Board Considers Telexcell Offer for Up to 25% Stake; Rejects Demand for ControlBY PTI
Economy & PolicyAmid Air of Uncertainty with Tariffs, Indian Pharma Firms May Look at More Third-party ManufacturingBY Outlook Business Desk
NewsTrump Targets Pharma Ads — New Rules for TV, Social Media & Telehealth: Here’s What Led to ItBY Outlook Business Desk
CorporateAmansa Investments Pumps ₹250 Cr in Rubicon Research in Pre-IPO Funding Round; Issue by Year-EndBY PTI
MarketsGlenmark Pharma Shares Surge 10% On Arm’s Landmark Deal with AbbVie For Cancer DrugBY Outlook Business Desk
MarketsSun Pharma Advanced Research Tumbles Over 18%: Here’s What Spooked InvestorsBY Outlook Business Desk
MagazineCorporate Strategist: After Winning India with Price, Mankind Pharma Chases Global Growth with PremiumBY Yuthika Bhargava
MarketsNew Product Launches Save the Day for Dr Reddy’s in Q4, But Margins Remain a Sour PillBY Harshita Dudeja
MarketsCipla, Lupin, Aurobindo Shares Drop as Trump’s Push to Boost US Drug Mfg Sours SentimentBY Outlook Business Desk
MarketsAs Trump’s April 2 Tariff Call Nears, These Indian Sectors Could be in TroubleBY Harshita Dudeja
MarketsNatco Pharma Shares Tank 19% Post Q3 Earnings: What Disappointed Investors?BY Outlook Business Desk
NewsCDSCO Flags 61 Medicines and Cosmetic Products as 'Not of Standard QualityBY Outlook Business Desk
NewsHealth Regulations Trigger Concerns Of Drug Shortages And Price Spikes In India, Says ReportBY Outlook Business Desk
NewsLeading 25 Domestic Pharma Cos Expected To See 9-11% Revenue Growth In FY24: IcraBY Press Trust of India
